Our client is a global powerhouse in the pharmaceutical and innovative medicine sector. They are currently pioneering a massive shift in how we treat complex, immune‑mediated diseases. Instead of just managing symptoms, the goal here is radical: disease state reversal.
By merging massive, cutting‑edge biological datasets (single‑cell genomics, proteomics, spatial transcriptomics) with advanced generative AI and machine learning, they are building a computational “time machine”. The project focuses on predicting exactly how human cells will respond to specific genetic or chemical tweaks, allowing scientists to find the perfect therapeutic targets before anyone ever steps into a physical lab.
As a Senior Scientist in Multiomics Perturbation, you are the architect of this predictive framework. You’ll bridge the gap between heavy‑data‑science and real‑world biology, taking complex data and turning it into ther...